LINEAGE CELL THERAPEUTICS IN shareholders Q3 2023

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

LINEAGE CELL THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Legal & General Group Plc 15,644$18,4600.00%
GEODE CAPITAL MANAGEMENT, LLC 2,766,937$3,265,5220.00%
STATE STREET CORP 2,022,846$2,386,9580.00%
SG Americas Securities, LLC 19,110$230.00%
PRICE T ROWE ASSOCIATES INC /MD/ 85,336$1010.00%
NEW YORK STATE COMMON RETIREMENT FUND 3,555$40.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 36,970$43,6250.00%
AMERIPRISE FINANCIAL INC 25,660$30,2790.00%
DEUTSCHE BANK AG\ 79,094$93,3300.00%
SCOTIA CAPITAL INC. 16,750$19,7650.00%
CITIGROUP INC 133,051$157,0000.00%
ST GERMAIN D J CO INC 2$20.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 363,215$428,5940.00%
GOLDMAN SACHS GROUP INC 29,890$35,2700.00%
MORGAN STANLEY 277,816$327,8230.00%
COMERICA BANK 295$3480.00%
Invesco Ltd. 65,892$77,7530.00%
Rathbones Group PLC 35,000$41,3000.00%
AMALGAMATED BANK 19,565$230.00%
NATIONAL BANK OF CANADA /FI/ 14$160.00%
External links

This page lists LINEAGE CELL THERAPEUTICS IN's shareholders in Q3 2023. To view LINEAGE CELL THERAPEUTICS IN's shareholder history, click here.